Page 6 - ஜெஃப்ரி போற்கேஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Blood disease treatment from CRISPR, Vertex shows promise in more patients

BioPharma

Geoffrey porgesEuropean hematology associationDive briefVertex pharmaceuticalGene therapyஜெஃப்ரி போற்கேஸ்ஐரோப்பிய ஹீமாட்டாலஜி சங்கம்டைவ் சுருக்கமானவெர்டெக்ஸ் மருந்துகீந் சிகிச்சை

Liberar patentes de vacunas contra el coronavirus: ¿qué implica para Costa Rica?

Liberar patentes de vacunas contra el coronavirus: ¿qué implica para Costa Rica?
nacion.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nacion.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomSouth africaSanofi pasteurSharon castilloEugenia corrales aguilarNobel afpGeoffrey porgesAntony fauciJoe bidenCentre for researchPlant emergent biosolutions incHealth of the expense ricanExpense ricanIncluding joe biden

FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript

FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. FibroGen Inc (NASDAQ: FGEN) Operator Good day, and welcome. Thank you for standing by. Welcome to the FibroGen First Quarter 2021 Financial Results Conference Call. [Operator Instructions] After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker for today, Mr. Michael Tung. Please go ahead.SPONSORED: 10 stocks we like better than FibroGen When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

United statesMichael tungLisa yang goldman sachsAndy hsiehJason gerberryEdwin zhangAnnabel samimyTricia stewartChristinel chungAnnabel samimy stifelAndy hsieh william blairPercy carterChris chungElias kouchakjiEnrique conternoMichael yee

Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call Transcript

Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Theravance Biopharma Inc (NASDAQ: TBPH) Popular Searches Operator Ladies and gentlemen, good afternoon. I d like to welcome everyone to the Theravance Biopharma First Quarter 2021 Conference Call. [Operator Instructions] [Operator Instructions] And now, I would like to turn the call over to Gail Cohen, Vice President Corporate Communications. Please go ahead.SPONSORED: 10 stocks we like better than Theravance Biopharma When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

New yorkUnited statesRick winninghamViatris theravance biopharmaDouglas tsaoAnupam rama jpmorganAnupam ramaChin leeGenentech lillyMarc frahm cowenAndrew hindmanVikram purohitLiisa baykoRicharda grahamMarc frahmGail cohen

Pressure mounts to lift patent protections on coronavirus vaccines

Pressure mounts to lift patent protections on coronavirus vaccines By Sheryl Gay Stolberg, Thomas Kaplan and Rebecca Robbins New York Times,Updated May 3, 2021, 9:50 p.m. Email to a Friend President Biden spoke at Tidewater Community College on Monday in Portsmouth, Va.Evan Vucci/Associated Press WASHINGTON â President Joe Biden, faced with surging COVID-19 crises in India and South America, is under intensifying pressure from the international community and his partyâs left flank to commit to increasing the vaccine supply by loosening patent and intellectual property protections on coronavirus vaccines. Pharmaceutical and biotech companies, also feeling pressure, sought on Monday to head off such a move, which could cut into future profits and jeopardize their business model. Pfizer and Moderna, two major vaccine-makers, each announced steps to increase the supply of vaccine around the world.

United statesUnited kingdomSouth africaCapitol hillDistrict of columbiaThe white houseGordon brownEllen johnson sirleafSharon castilloShantha biotechnicsAaron kesselheimAlbert bourlaBill gatesElizabeth warrenAnthony fauciRo khanna